The EpiShuttle was used in a simulation exercise organized by the Organization for the Prohibition of Chemical Weapons as a tool for strengthening national preparedness for CBRN events.
EpiShuttle’s first time in Japan! EpiGuard attended DSEI in Tokio and had a demonstration in Kyoto. Read more about it in the blog!
EpiGuard is proud to announce that the EpiShuttle has been approved by the Therapeutic Goods Administration (TGA) and is now available for use in the Australian market!
EpiGuard’s commitment to safety and quality was attested by our successful completion of an audit by the Norwegian Medicines Agency last June.
It’s been an exciting summer at EpiGuard, with the launch of our new e-Learning platform and the appointment of our new CEO, Michael Eimstad.
Be prepared for next Disease X! EpiShuttle e-learning will make patient isolation and transportation safer and more efficient!
Finland is investing in the future safety of their citizens by increasing national preparedness for pandemics and CBRNe events with EpiShuttles!
EpiGuard is proud to announce a new exclusive partnership with Leader Healthcare Group!
EpiGuard has been ISO 13485:2016 certified for developing innovative solutions that are safe, high-quality, and effective.
FAI has obtained supplementary type certification (STC) for the EpiShuttle on the aircraft type CL-600 after undergoing tests on flammability, rapid decompression, and patient evacuation.
